Cargando…
Effect of significant weight loss on disease activity: reason to implement this non-pharmaceutical intervention in daily clinical practice
Obesity is very common in patients with inflammatory rheumatic diseases (IRDs), of which between 27% and 37% of patients have a body mass index ≥30 kg/m(2). In addition to further increasing the risk of developing cardiovascular diseases (CVDs) in this group of patients, obesity is associated with h...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843325/ https://www.ncbi.nlm.nih.gov/pubmed/33504577 http://dx.doi.org/10.1136/rmdopen-2020-001498 |